Skip to Main Content

Paper Details

Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients With Urothelial Carcinoma.
Clin Pharmacol Ther
39
2018
PD-L1, Patients, UC, Urothelial Carcinoma, albumin, anti-PD-L1 monoclonal, cancer, hemoglobin, immune-cell, liver metastasis, locally advanced or metastatic urothelial carcinoma, patient, patients, platinum, tumor

Datasets

Release 1.2